MeSH D016585 - bacterial vaginosis
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Teva | Clindamycin | Clindamycin |  | 1989-09-20 |  |  |
| Metronidazole | Metronidazole |  | 1984-11-06 |  |  | |
| Metronidazole | Vandazole | 2024-09-22 | 2005-05-20 |  |  | |
| Novast Laboratories | Clindamycin | Clindamycin |  | 1996-09-27 |  |  |
| Metronidazole, Tetracycline | Bismuth Subcitrate Potassium, Metronidazole Tetracycline |  | 2023-07-03 |  |  | |
| Padagis | Clindamycin | Clindamycin |  | 1995-11-30 |  |  |
| Clindamycin, Benzoyl peroxide | Clindamycin Benzoyl Peroxide |  | 2012-06-26 |  |  | |
| Clindamycin | Clinderm |  | 1992-09-30 |  |  | |
| Clindamycin | Clindesse | 2023-04-27 | 2004-11-30 |  |  | |
| Clindamycin | Clindets |  | 1996-09-30 |  |  | |
| Metronidazole | Metronidazole |  | 2019-07-02 |  |  | |
| Taro Pharmaceutical | Clindamycin | Clindamycin |  | 2004-03-31 |  |  |
| Clindamycin, Benzoyl peroxide | Clindamycin Benzoyl Peroxide |  | 2017-12-15 |  |  | |
| Metronidazole | Metronidazole |  | 2006-07-18 |  |  | |
| Glenmark Pharmaceuticals | Clindamycin | Clindamycin |  | 2021-09-20 |  |  |
| Clindamycin, Benzoyl peroxide | Clindamycin Benzoyl Peroxide |  | 2019-03-14 |  |  | |
| Metronidazole | Metronidazole |  | 2022-01-27 |  |  | |
| Mylan | Clindamycin | Clindamycin |  | 2011-05-31 |  |  |
| Clindamycin, Benzoyl peroxide | Clindamycin Benzoyl Peroxide |  | 2009-08-11 |  |  | |
| Clindamycin | Evoclin | 2024-01-23 | 2004-10-22 |  |  | |
| Rising Pharmaceuticals | Clindamycin | Clindamycin |  | 2016-05-25 |  |  |
| Metronidazole | Metronidazole |  | 2017-05-09 |  |  | |
| Johnson & Johnson | Metronidazole | Protostat |  | 1983-03-02 |  |  |
| Almirall | Clindamycin, Tretinoin | Veltin |  | 2010-07-16 |  |  |
| Lupin Research | Metronidazole | Metronidazole |  | 2017-09-12 |  |  |
1
2
3
4
5
6
7
>
Clinical Trials
Historical Success Rate
Phase 1
100%9/9
Phase 2
80%8/10
Phase 3
39%13/33
Approved: 4Overall Success rate: 32%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
3
4
5
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use